000 | 01946cam a2200337 a 4500 | ||
---|---|---|---|
003 | EG-GiCUC | ||
005 | 20250223030300.0 | ||
008 | 100926s2010 ua dh f m 000 0 eng d | ||
040 |
_aEG-GiCUC _beng _cEG-GiCUC |
||
041 | 0 | _aeng | |
049 | _aDeposite | ||
097 | _aPh.D | ||
099 | _aCai01.12.02.Ph.D.2010.Fa.A | ||
100 | 0 | _aFatma Baiuomy Rashedy Abdallah | |
245 | 1 | 0 |
_aAntibody directed enzyme prodrug therapy : _bMolecular studies on carboxypeptidase G2 , production by DNA shuffling of novel variants of CPG2 for more efficient cancer treatment / _cFatma Baiuomy Rashedy Abdallah ; Supervised Abdalla M. Negm , Ahmed I. Amien |
246 | 1 | 5 |
_aعلاج مرض السرطان بإستخدام جسم مضاد موجه ومحمل بإنزيم الكربوكسى بيبتيديزجى2 : _bدراسات جزيئية على هذا الانزيم : وانتاج مشابهات لهذا الانزيم ذو كفاءة اعلى من خلال تكنولوجيا قص وخلط وإعادة لصق الجين |
260 |
_aCairo : _bFatma Baiuomy Rashedy Abdallah , _c2010 |
||
300 |
_a246P. : _bcharts , facsimiles ; _c25cm |
||
502 | _aThesis (Ph.D.) - Cairo University - Faculty of Science - Department of Biochemistry | ||
520 | _aGlucarpidase (former name : carboxypeptidase G2, or CPG2 ) is a bacterial enzyme that is widely used in detoxification of the cytotoxic drug methotrexate and in Antibody Directed Enzme Prodrug Therapy ( ADEPT ) for cancer treatment . In this study we report three achievements in relation to the CPG2 enzyme and the ADEPT for cancer treatment | ||
530 | _aIssued also as CD | ||
653 | 4 | _aADEPT | |
653 | 4 | _aCPG2 overexpression | |
653 | 4 | _aSynthetic carboxypeptidase G2 | |
700 | 0 |
_aAbdalla M. Negm , _eSupervisor |
|
700 | 0 |
_aAhmed I. Amien , _eSupervisor |
|
856 | _uhttp://172.23.153.220/th.pdf | ||
905 |
_aFatma _eCataloger |
||
905 |
_aNazla _eRevisor |
||
942 |
_2ddc _cTH |
||
999 |
_c31480 _d31480 |